Bioactive nanoparticles improve calcium handling in failing cardiac myocytes

Nanomedicine

Volumn 10, Issue 22, 2015, Pages 3343-3357

  Maxwell, Joshua T ^a,b,c   Somasuntharam, Inthirai ^a   Gray, Warren D ^a   Shen, Ming ^b,c   Singer, Jason M ^b,c   Wang, Bo ^b,c   Saafir, Talib ^b,c   Crawford, Brian H ^b,c   Jiang, Rong ^b,c   Murthy, Niren ^d   Davis, Michael E ^a,b,c   Wagner, Mary B ^b,c  

^a Emory University   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^d University of California at Berkeley   (United States)

Author keywords

biomolecules; calcium handling; cardiac myocytes; encapsulation; GlcNAc; heart failure; nanoparticles; S100A1

Indexed keywords

CALCIUM; N ACETYLGLUCOSAMINE; NANOPARTICLE; PROTEIN S 100; S100A1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CELL ISOLATION; CONTROLLED STUDY; FLOW CYTOMETRY; HEART FAILURE; HEART MUSCLE CELL; IMMUNOPRECIPITATION; INTERNALIZATION; LUNG ARTERY BANDING; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; TARGET CELL; WESTERN BLOTTING; CALCIUM SIGNALING; CARDIAC MUSCLE CELL; CHEMISTRY; DRUG EFFECTS; HUMAN; METABOLISM; PATHOLOGY; SARCOMERE;

ACETYLGLUCOSAMINE; CALCIUM; CALCIUM SIGNALING; HEART FAILURE; HUMANS; MYOCYTES, CARDIAC; NANOPARTICLES; S100 PROTEINS; SARCOMERES;

EID: 84948389407     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.15.126     Document Type: Article

References (41)

1. Lindner M, Erdmann E, Beuckelmann DJ. Calcium content of the sarcoplasmic reticulum in isolated ventricular myocytes from patients with terminal heart failure. J. Mol. Cell. Cardiol. 30(4), 743-749 (1998).
2. Pieske B, Maier LS, Bers DM, Hasenfuss G. Ca2+ handling and sarcoplasmic reticulum Ca2+ content in isolated failing and nonfailing human myocardium. Circ. Res. 85(1), 38-46 (1999).
3. Pogwizd SM, Schlotthauer K, Li L, Yuan W, Bers DM. Arrhythmogenesis and contractile dysfunction in heart failure: roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-Adrenergic responsiveness. Circ. Res. 88(11), 1159-1167 (2001).
4. Shannon TR, Pogwizd SM, Bers DM. Elevated sarcoplasmic reticulum Ca2+ leak in intact ventricular myocytes from rabbits in heart failure. Circ. Res. 93(7), 592-594 (2003).
5. Guo T, Ai X, Shannon TR, Pogwizd SM, Bers DM. Intra-sarcoplasmic reticulum free [Ca2+] and buffering in arrhythmogenic failing rabbit heart. Circ. Res. 101(8), 802-810 (2007).
6. Maxwell JT, Domeier TL, Blatter LA. Dantrolene prevents arrhythmogenic Ca2+ release in heart failure. Am. J. Physiol. Heart Circ. Physiol. 302(4), H953-H963 (2012).
7. George CH. Sarcoplasmic reticulum Ca2+ leak in heart failure: mere observation or functional relevance? Cardiovasc. Res. 77(2), 302-314 (2008).
8. Most P, Bernotat J, Ehlermann P, et al. S100A1: a regulator of myocardial contractility. Proc. Natl Acad. Sci. USA 98(24), 13889-13894 (2001).
9. Most P, Remppis A, Pleger ST, et al. Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance. J. Biol. Chem. 278(36), 33809-33817 (2003).
10. Volkers M, Loughrey CM, Macquaide N, et al. S100A1 decreases calcium spark frequency and alters their spatial characteristics in permeabilized adult ventricular cardiomyocytes. Cell Calcium 41(2), 135-143 (2007).
11. Pleger ST, Shan C, Ksienzyk J, et al. Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model. Sci. Transl. Med. 3(92), 92ra64 (2011).
12. Brinks H, Rohde D, Voelkers M, et al. S100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytes. J. Am. Coll. Cardiol. 58(9), 966-973 (2011).
13. Gray WD, Che P, Brown M, Ning X, Murthy N, Davis ME. N-Acetylglucosamine conjugated to nanoparticles enhances myocyte uptake and improves delivery of a small molecule p38 inhibitor for post-infarct healing. J. Cardiovasc. Transl. Res. 4(5), 631-643 (2011).
14. Marsh SA, Collins HE, Chatham JC. Protein O-GlcnAcylation and cardiovascular (patho)physiology. J. Biol. Chem. 289(50), 34449-34456 (2014).
15. Song X, Qian X, Shen M, et al. Protein kinase C promotes cardiac fibrosis and heart failure by modulating galectin-3 expression. Biochim. Biophys. Acta 1853(2), 513-521 (2015).
16. Wang Y, Joyner RW, Wagner MB, Cheng J, Lai D, Crawford BH. Stretch-Activated channel activation promotes early afterdepolarizations in rat ventricular myocytes under oxidative stress. Am. J. Physiol. Heart Circ. Physiol. 296(5), H1227-H1235 (2009).
17. Lee S, Yang SC, Heffernan MJ, Taylor WR, Murthy N. Polyketal microparticles: a new delivery vehicle for superoxide dismutase. Bioconjug. Chem. 18(1), 4-7 (2007).
18. Sy JC, Seshadri G, Yang SC, et al. Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction. Nat. Mater. 7(11), 863-868 (2008).
19. Cheng H, Lederer WJ, Cannell MB. Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle. Science 262(5134), 740-744 (1993).
20. Volkers M, Loughrey CM, Macquaide N, et al. S100a1 decreases calcium spark frequency and alters their spatial characteristics in permeabilized adult ventricular cardiomyocytes. Cell Calcium 41(2), 135-143 (2007).
21. Rohde D, Schon C, Boerries M, et al. S100a1 is released from ischemic cardiomyocytes and signals myocardial damage via toll-like receptor 4. EMBO Mol. Med. 6(6), 778-794 (2014).
22. Most P, Lerchenmuller C, Rengo G, et al. S100a1 deficiency impairs postischemic angiogenesis via compromised proangiogenic endothelial cell function and nitric oxide synthase regulation. Circ. Res. 112(1), 66-78 (2013).
23. Treves S, Scutari E, Robert M, et al. Interaction of S100A1 with the Ca2+ release channel (ryanodine receptor) of skeletal muscle. Biochemistry 36(38), 11496-11503 (1997).
24. Wright NT, Prosser BL, Varney KM, Zimmer DB, Schneider MF, Weber DJ. S100A1 and calmodulin compete for the same binding site on ryanodine receptor. J. Biol. Chem. 283(39), 26676-26683 (2008).
25. Ai X, Curran JW, Shannon TR, Bers DM, Pogwizd SM. Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure. Circ. Res. 97(12), 1314-1322 (2005).
26. Marx SO, Reiken S, Hisamatsu Y, et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101(4), 365-376 (2000).
27. Reiken S, Gaburjakova M, Guatimosim S, et al. Protein kinase a phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts. Role of phosphatases and response to isoproterenol. J. Biol. Chem. 278(1), 444-453 (2003).
28. Wehrens XH, Lehnart SE, Reiken SR, Marks AR. Ca2+/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor. Circ. Res. 94(6), e61-e70 (2004).
29. Bassani RA, Bers DM. Rate of diastolic Ca release from the sarcoplasmic reticulum of intact rabbit and rat ventricular myocytes. Biophys. J. 68(5), 2015-2022 (1995).
30. Thandroyen FT, Morris AC, Hagler HK, et al. Intracellular calcium transients and arrhythmia in isolated heart cells. Circ. Res. 69(3), 810-819 (1991).
31. Most P, Boerries M, Eicher C, et al. Distinct subcellular location of the Ca2+-binding protein s100a1 differentially modulates Ca2+-cycling in ventricular rat cardiomyocytes. J. Cell Sci. 118(Pt 2), 421-431 (2005).
32. Most P, Seifert H, Gao E, et al. Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction. Circulation 114(12), 1258-1268 (2006).
33. Most P, Boerries M, Eicher C, et al. Distinct subcellular location of the Ca2+-binding protein S100A1 differentially modulates Ca2+-cycling in ventricular rat cardiomyocytes. J. Cell Sci. 118(Pt 2), 421-431 (2005).
34. Aso S-I, Ise H, Takahashi M, et al. Effective uptake of N-Acetylglucosamine-conjugated liposomes by cardiomyocytes in vitro. J. Control. Release 122(2), 189-198 (2007).
35. Monsigny M, Roche A-C, Midoux P, Mayer R. Glycoconjugates as carriers for specific delivery of therapeutic drugs and genes. Adv. Drug Deliv. Rev. 14(1), 1-24 (1994).
36. Weis WI, Drickamer K. Structural basis of lectincarbohydrate recognition. Annu. Rev. Biochem. 65(1), 441-473 (1996).
37. Ise H, Kobayashi S, Goto M, et al. Vimentin and desmin possess GlcNAc-binding lectin-like properties on cell surfaces. Glycobiology 20(7), 843-864 (2010).
38. Marsh SA, Collins HE, Chatham JC. Protein O-GlcNAcylation and cardiovascular (patho)physiology. J. Biol. Chem. 289(50), 34449-34456 (2014).
39. Johnsen VL, Belke DD, Hughey CC, et al. Enhanced cardiac protein glycosylation (O-GlcNAc) of selected mitochondrial proteins in rats artificially selected for low running capacity. Physiol. Genomics 45(1), 17-25 (2013).
40. Rengifo J, Gibson CJ, Winkler E, Collin T, Ehrlich BE. Regulation of the inositol 1, 4, 5-Drisphosphate receptor type I by O-GlcNAc glycosylation. J. Neurosci. 27(50), 13813-13821 (2007).
41. Champattanachai V, Marchase RB, Chatham JC. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein O-GlcNAc and increased mitochondrial Bcl-2. Am. J. Physiol. Cell Physiol. 294(6), C1509-C1520 (2008).